Mariner’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58K | Buy |
27,508
+1,092
| +4% | +$2.3K | ﹤0.01% | 3327 |
|
|
2025
Q1 | $32.2K | Sell |
26,416
-911
| -3% | -$1.11K | ﹤0.01% | 3337 |
|
|
2024
Q4 | $35.3K | Buy |
27,327
+742
| +3% | +$957 | ﹤0.01% | 3320 |
|
|
2024
Q3 | $73.1K | Buy |
26,585
+109
| +0.4% | +$300 | ﹤0.01% | 3139 |
|
|
2024
Q2 | $59.8K | Sell |
26,476
-1,902
| -7% | -$4.3K | ﹤0.01% | 3025 |
|
|
2024
Q1 | $67.8K | Buy |
28,378
+17,500
| +161% | +$41.8K | ﹤0.01% | 2992 |
|
|
2023
Q4 | $18.1K | Hold |
10,878
| – | – | ﹤0.01% | 3006 |
|
|
2023
Q3 | $20.9K | Buy |
10,878
+78
| +0.7% | +$150 | ﹤0.01% | 2841 |
|
|
2023
Q2 | $15.6K | Hold |
10,800
| – | – | ﹤0.01% | 2793 |
|
|
2023
Q1 | $23K | Hold |
10,800
| – | – | ﹤0.01% | 2718 |
|
|
2022
Q4 | $12K | Sell |
10,800
-567
| -5% | -$630 | ﹤0.01% | 2711 |
|
|
2022
Q3 | $19K | Buy |
+11,367
| New | +$19K | ﹤0.01% | 2380 |
|